New Delhi: Drug firm Ranbaxy Laboratories
today said its shareholders have approved the appointment of
Atul Sobti as CEO and Managing Director of the company for a
period three years through the postal ballot.
Through postal ballot notice dated July 31, 2009, the
company's shareholder have approved the appointment Atul Sobti
as Chief Executive Officer and Managing Director of Ranbaxy
for three years effective from May 24, 2009, the company said
in a filing to Bombay Stock Exchange.
"Thus the resolution for which poll was conducted, stand
duly approved by the shareholders with overwhelming majority,"
Ranbaxy said.
Bureau Report
First Published: Tuesday, September 22, 2009, 21:56